Registration and forms

Admission criteria CTO program
PhD candidates have to meet the admission criteria as formulated by the Graduate School of Life Sciences of Utrecht University. 


PhD studies at Utrecht University   

Graduate School of Life Sciences  


PhD candidates have to participate in (clinical) cancer-research projects carried out in, or associated with one of the departments of the UMC Utrecht, Faculty of Science/Biology (UU), Faculty of Veterinary Medicine (UU) or the Hubrecht Laboratory. Minimum number of PhD years is two.

Training and Supervision Agreement (TSA)
Within two months after the start of their PhD project, all PhD candidates fill in the Training Supervision Agreement (TSA) of the Graduate School of Life Sciences. The TSA has to be signed by several people (indicated in the form) and is then sent to the program coordinator for approval. After approval a copy is returned to the PhD candidate and a copy is kept by the program coordinator. The original agreement will be kept on file by the administrative office of appointment.


Exemption and Admission to Doctoral Studies
Immediately upon approval of the training program, the PhD candidate has to request "Exemption and Admission to Doctoral Studies" (NL: "Verzoek tot ontheffing en toelating tot de promotie"). The request can be made via the following UU website:  Doctoral Programmes at University Utrecht


Monitoring is performed according to the procedures proposed by the GS-LS. The PhD candidate receives guidance on a regular basis by his/her supervisors. On a yearly basis the supervisors evaluates the progress of the research project and training program. The PhD candidate documents this yearly evaluation in a written report. The yearly report is sent to the program coordinator.


*Please only register for a course when the course is open for registration



Advanced Molecular Pathology Course,

(formerly known as Modern Cancer Pathology Course):

Only for participants CTO PhD programme for free!

17-18-19 June 2019


Comments last course:

"Very good course, very informative! Great speakers"


"Interesting, useful to a broad spectrum"


"Practical sessions were fantastic. They were provoking, challenging and fun"


Translational Immuno-oncology: cancer & immune therapies from bench to bedside

11-12-13-14 November 2019


Clinical Trial and Development Course,

27-28-29 November 2019


Comments last course:


"Excellent in all aspects"


"Very interactive and informative"


"I really enjoyed it!"


Viagra kopen online goedkoop Http:// Cialis